BLACKBOX® LASV IgG ELISA Kit
- Tagged as
- - ELISA
- - Derived product
- - Detection Kit (for RUO)
Produced by: BNI-DDL
Shipping From: Hamburg - DE
Kit for the qualitative detection of human IgG, directed against Lassa virus nucleoprotein, in human sera. The test uses the BNITM-patented immune complex capture principle. See publication and Instructions For Use for further details.
Product Risk Group:
Information on the related virus
Can it be used to produce GMO:
BSL1, all samples should be inactivated prior to testing (do not use heat inactivation). All samples should be considered potentially infectious.
+ 4°C and dry ice
NON DANGEROUS GOODS
Storage of the kit is at refrigerated temperatures, except for the Conjugate and HRP-Streptavidin, which must be removed and stored separately at -20°C. Storage condition is selected as 'Dried' due to lack of a custom entry option.
99.3% specific compared to historical clinical data in samples from Lassa virus endemic regions. 94.7% and 91.2% sensitive compared to the reference method and historical clinical data, respectively. Data from FIND evaluation report 03-JUNE-2021 (not published).
Virus host type:
For larger orders, shipping costs may be reduced by arrangement, through supply of condensed reagent units. Also, where full plates will be processed, rather than individual processing of each of the 12 single 8-well strips, reagent volumes may also be reduced in order to allow compact shipping for reduced shipping cost. These customisations must be organised prior to kit batch assembly. The per-unit cost for the kits is not affected by these customisations. For some countries, shipping delays may be expected due to import permit acquisition. This product is part of a technology transfer proceeding and may be supplied at a later stage by a commercial entity, please contact email@example.com for details.